Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
16.65
+0.88 (5.58%)
Mar 20, 2026, 1:12 PM EDT - Market open

TNXP Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
13.1110.097.77--
Revenue Growth (YoY)
29.85%29.94%---
Cost of Revenue
6.647.774.74--
Gross Profit
6.472.333.03--
Selling, General & Admin
87.6840.134.7530.2223.47
Research & Development
44.4939.9786.6681.8868.84
Other Operating Expenses
-58.96---
Total Operating Expenses
132.17139.03121.41112.0992.31
Operating Income
-125.7-136.7-118.38-112.09-92.31
Interest Income
4.150.02--0.03
Interest Expense
-0.09-1.23---
Other Non-Operating Income (Expense)
-2.387.881.721.87-
Total Non-Operating Income (Expense)
1.686.671.721.870.03
Pretax Income
-124.02-130.04-116.66-110.22-92.29
Net Income
-124.02-130.04-116.66-116.88-92.29
Net Income Attributable to Preferred Dividends
---6.66-
Net Income to Common
-124.02-130.04-116.66-116.88-92.29
Shares Outstanding (Basic)
91000
Shares Outstanding (Diluted)
91000
Shares Change (YoY)
1055.90%9191.34%334.14%220.61%285.23%
EPS (Basic)
-14.57-176.60-14720.25-64032.00-162000.00
EPS (Diluted)
-14.57-176.60-14720.25-64032.00-162000.00
Free Cash Flow
-103.21-61.05-109.9-146.2-110.86
Free Cash Flow Per Share
-12.13-82.90-13867.26-80089.74-194715.03
Gross Margin
49.34%23.07%38.97%--
Operating Margin
-959.05%-1354.28%-1523.94%--
Profit Margin
-946.22%-1288.25%-1501.78%--
FCF Margin
-787.46%-604.77%-1414.75%--
EBITDA
-123.78-133.28-114.09-110.84-92.26
EBITDA Margin
-944.37%-1320.39%-1468.70%--
EBIT
-125.7-136.7-118.38-112.09-92.31
EBIT Margin
-959.05%-1354.28%-1523.94%--
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q